Institut Pasteur de Madagascar
15
2
2
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 15 trials
100.0%
+13.5% vs industry average
27%
4 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar
Role: collaborator
Impact of a Cricket and Black Soldier Fly Larvae-Fortified Cracker on the Gut Microbiome and Iron Status in Malagasy Schoolchildren
Role: collaborator
Comparing a Novel Point-of-care Cytokine Biomarker Lateral Flow Test With Nucleic Acid Amplification Tests for Detection of Sexually Transmitted Infections and Bacterial Vaginosis
Role: collaborator
Ciprofloxacin Versus an Aminoglycoside Followed by Ciprofloxacin for Bubonic Plague
Role: collaborator
Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa
Role: collaborator
Whole Genome Sequencing of Tuberculosis for Disease Control in Madagascar
Role: lead
Dried Blood Spot Test to Assess TB in Pregnancy
Role: lead
Immunity Persistence After Abridged Intradermal Rabies PEP
Role: collaborator
Yersinia Pestis Lateral Flow Immunoassay for Blood Samples
Role: collaborator
Neonatal Acquisition of ESBL-PE in a Low-income Country - NeoLIC
Role: collaborator
Epidemiological Study In Tuberculosis-Endemic Urban Area in Senegal
Role: collaborator
Comparing Several Strategies to Manage Moderate Acute Malnutrition Among Children From 6 to 24 Months Old
Role: collaborator
Pertussis Immunization Programs in Low Income Countries
Role: collaborator
Proactive Community Case Management (Pro-CCM) in Rural Madagascar
Role: lead
ACT for the Home Management in Malagasy Children
Role: collaborator
All 15 trials loaded